FDA approves Shire’s Xiidra for dry eye disease
12 July 2016 | By Victoria White, Digital Content Producer
With this approval, Xiidra is the only prescription eye drop indicated for the treatment of both signs and symptoms of this condition...
List view / Grid view
News
SMC accepts five new medicines for use in NHS Scotland
11 July 2016 | By Victoria White, Digital Content Producer
The SMC has accepted five new medicines for routine use in NHS Scotland including lung cancer treatments nivolumab and crizotinib...
Celyad and ONO strike deal for NKR-2 in Japan, Korea and Taiwan
11 July 2016 | By Victoria White, Digital Content Producer
This license agreement opens new markets to Celyad and expands the global footprint of its NKR-2 T-cell cancer immunotherapy treatment...
FDA approves Xolair to treat allergic asthma in children
11 July 2016 | By Victoria White, Digital Content Producer
The FDA has approved Genentech’s Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age...
Trial of RVT-101 in Alzheimer’s disease starts at Plymouth Science Park
11 July 2016 | By Victoria White, Digital Content Producer
If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002...
Martindale expands hospital-initiated medicines portfolio through Viridian acquisition
11 July 2016 | By Victoria White, Digital Content Producer
Viridian Pharma has developed five products that have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines...
Positive trial results for Sutent as adjuvant therapy in RCC
8 July 2016 | By Victoria White, Digital Content Producer
The S-TRAC study of Sutent versus placebo in the adjuvant setting met its primary endpoint of improving disease-free survival in renal cell carcinoma...
Eisai calls for immediate solution to CDF black hole
8 July 2016 | By Victoria White, Digital Content Producer
Eisai has expressed concern that patients in England and Wales will have to wait three years to access Lenvatinib due to a ‘black hole’ in the CDF process...
CPhI Korea sees 25% growth as domestic pharma economy forecast to become 7th globally by 2020
8 July 2016 | By CPhI
CPhI Korea is experiencing a huge surge in interest; with over 5000 pharma professionals envisaged to converge at the COEX centre during the three-day event...
NHS England gives patients with nmDMD access to Translarna
7 July 2016 | By Victoria White, Digital Content Producer
This important decision allows reimbursed access to Translarna, the first approved therapy to treat the underlying cause of Duchenne muscular dystrophy...
AbbVie announces study data for Humira in fingernail psoriasis
7 July 2016 | By Victoria White, Digital Content Producer
Nearly half of adult patients treated with Humira achieved at least a 75% improvement in their fingernail psoriasis compared to patients receiving placebo...
Shire gets extended Marketing Authorisation for Revestive
7 July 2016 | By Victoria White, Digital Content Producer
The EC has granted an extension of the Market Authorisation for Revestive for the treatment of patients aged one year and above with Short Bowel Syndrome...
Sandoz announces EGALITY trial results for biosimilar etanercept
7 July 2016 | By Victoria White, Digital Content Producer
The EGALITY study involved 531 patients and compared the efficacy and safety of biosimilar etanercept with the originator product, Enbrel...
NICE says ‘yes ‘ to bosutinib for chronic myeloid leukaemia
7 July 2016 | By Victoria White, Digital Content Producer
Bosutinib is the first drug to go through the reappraisal process, where NICE assesses the cost and clinical effectiveness of drugs currently in the old CDF...
EMA issues statement on the outcome of the EU Referendum
7 July 2016 | By Victoria White, Digital Content Producer
In the recent Referendum, the majority voted against the UK's continued membership of the EU. Now, the EMA has issued a statement on the outcome of the vote...
